Gary Gonzales

Gary Gonzales, MS, MBA, is a seasoned drug development professional with over 26 years of industry experience in academic, biotechnology, and CRO settings.

During his 10-year tenure, Gary played a pivotal role in the development stages of Lemtrada™ (alemtuzumab), contributing directly to each phase of the program.

His expertise spans across pre-phase II/III activities including study feasibility, protocol design, regulatory interactions, and collaboration with medical experts, as well as Phase II/III activities such as pivotal trial management and database locking, and marketing application filing.

Gary Gonzales holds an impressive educational background, having studied Master of Business Administration (MBA), Master of Science (MS) in Biology, Graduate Certification in Project Management, and a Bachelor of Science (BS) in Biology/Chemistry from renowned institutions like the University of the Incarnate Word and St. Mary's University.

With a wealth of experience in the pharmaceutical industry, Gary has held key positions in reputable organizations such as Parexel, XBiotech USA Inc., INC Research, Genzyme, and Quintiles, covering roles from Director to Clinical Research Associate.

His professional journey includes roles like Director of Global Project Management, Vice President of Clinical Operations, Senior Director of Clinical Development, Associate Director of Clinical Research, Clinical Project Manager, Senior Clinical Research Associate, and Clinical Research Associate.

Gary Gonzales also honed his skills early in his career with positions as Research Assistant II, Associate Clinical Data Analyst, Laboratory Technician, and Research Assistant at prestigious institutions like ILEX Oncology and the University of Texas Health Science Center at San Antonio.

Overall, Gary Gonzales is a versatile professional with a strong background in drug development, project management, clinical operations, and clinical research, making him a valuable asset in the pharmaceutical industry.